Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
A Study to Compare the Efficacy and Safety of JHL1101 Versus Rituximab in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT03670901. IPD Sharing: NO. Countries: 1. Publications: 0.
Tegavivint for Treating Patients With Relapsed or Refractory Large B-Cell Lymphoma
ClinicalTrials.gov study NCT05755087. IPD Sharing: NO. Countries: 1. Publications: 0.
Study Evaluating TRU-015 in B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00521638. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Relmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell Lymphoma
ClinicalTrials.gov study NCT05590221. IPD Sharing: NO. Countries: 1. Publications: 0.
Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT05806580. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Randomized Study With R-DHAP +/- Bortezomib as Induction Therapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Patients Eligible to Transplantation. BR-DHAP Versus R-DHAP.
ClinicalTrials.gov study NCT01805557. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CAR-NK Targeted CD19 for r/r B-cell Malignancies
ClinicalTrials.gov study NCT05645601. IPD Sharing: NO. Countries: 1. Publications: 0.
Interleukin-2 Following 4SCAR19/22 T Cells Targeting Refractory and/or Recurrent B Cell Malignancies
ClinicalTrials.gov study NCT03098355. IPD Sharing: NO. Countries: 1. Publications: 0.
Immunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLL
ClinicalTrials.gov study NCT02546739. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-CD22 CAR-T Cell Therapy Targeting B Cell Malignancies
ClinicalTrials.gov study NCT03262298. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
CAR T Cells for Refractory B Cell Malignancy
ClinicalTrials.gov study NCT02963038. IPD Sharing: NO. Countries: 1. Publications: 0.
JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
ClinicalTrials.gov study NCT06890065. IPD Sharing: NO. Countries: 1. Publications: 0.
Low-dose Radiotherapy for Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02803840. IPD Sharing: NO. Countries: 1. Publications: 0.
Genomic Evaluation in Patients With Diffuse Large B Cell Lymphoma After First Relapse/Progression
ClinicalTrials.gov study NCT03977623. IPD Sharing: NO. Countries: 1. Publications: 0.
Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma
ClinicalTrials.gov study NCT06919939. IPD Sharing: NO. Countries: 1. Publications: 0.
Risk Adapted Therapy in Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT03188198. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of Human Umbilical Cord Mesenchymal Stem Cell in Patients With Cirrhosis Due to Hepatitis B (Compensation Stage)
ClinicalTrials.gov study NCT05507762. IPD Sharing: YES. Countries: 1. Publications: 0.
Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy
ClinicalTrials.gov study NCT05075603. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT07192237. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT05322330. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.